Central registry - registration required - notice - repeal.

Checkout our iOS App for a better way to browser and research.

(1) (a) On or before July 1, 2020, the department shall develop or procure a secure online central registry, referred to in this section as the "registry", to register patients treated in a substance use disorder treatment program.

  1. The department shall operate and maintain the registry or enter into an agreementwith a third party to operate and maintain the registry on its behalf.

  2. Each opioid treatment program shall register and maintain an account with the registry.

  3. (I) The executive director shall notify in writing the health and human services committee of the senate and the public health care and human services committee of the house of representatives, or their successor committees, of the date on which the department has implemented the registry described in subsection (1)(a) of this section.

(II) This subsection (1)(d) is repealed, effective July 1, 2021.

(2) (a) (I) In order to prevent simultaneous enrollment of a patient in more than one opioid treatment program, each opioid treatment program shall fully participate in the registry, including submitting a query to the registry for each patient and entering in patient information as required by this part 2 and department rule.

  1. For each patient, the entry into the registry must include the patient's name, the opioid treatment program providing treatment to the patient, and any information the department deems necessary to further the goals of this part 2.

  2. Any person seeking treatment from an opioid treatment program must provide theprogram with any information required by this section and authorize the program to query the registry. A program may not query or enter any information into the registry without authorization from the patient.

(b) The department shall establish the method for opioid treatment programs to enter information into the registry and query the registry for information concerning prospective patients.

(3) (a) This section is repealed, effective September 1, 2026.

(b) Prior to the repeal, the department of regulatory agencies shall review the registration functions of the department as provided in section 24-34-104.

Source: L. 2019: Entire section added, (SB 19-219), ch. 277, p. 2616, § 9, effective August 2.


Download our app to see the most-to-date content.